UpToDate Lexidrug vs its rivals

Side-by-side comparison against UpToDate Lexidrug's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

Core Identity
DeveloperLexi-CompDrugs.comMerck & Co IncAntimicrobial Therapy, Inc.MerativeFigure 1, Inc.WebMDEBSCO PublishingDrugs.com
CategoryMedicalMedicalMedicalMedicalMedicalMedicalMedicalMedicalMedical
PlatformAndroid, iOSAndroid, iOSiOS, AndroidiOS, AndroidiOS, AndroidiOS, AndroidiOS, AndroidiOS, AndroidiOS, Android
Store Metrics
Rating4.7 / 54.8 / 54.8 / 54.8 / 53.4 / 54.7 / 54.8 / 54.9 / 53.4 / 5
Ratings Count3,74913,8549991,844351,3525,0863,491142
PriceFreeFreeFreeFreeFreeFreeFreeFree$0.99
Release DateJun 22, 2009Mar 1, 2013Sep 23, 2009Aug 28, 2014Oct 23, 2024May 21, 2013Mar 20, 2010May 2, 2015Oct 21, 2010
Last UpdatedMay 11, 2026Apr 15, 2026Mar 13, 2026Apr 13, 2026Oct 8, 2025Apr 7, 2026Dec 19, 2025Dec 19, 2025Apr 9, 2026
Sentiment & Reviews
Sentimentnegativepositive------negative
Score25/10065/100------25/100
Praises
  • Reliable clinical reference content remains a daily essential for medical professionals in clinical settings
  • Medication Management & Information
  • Pill Identification
------
  • Utility for Identification
Complaints
  • Persistent database download failures prevent access to critical drug interactions and compatibility information
  • UI navigation changes hide essential drug library tools behind excessive menu clicks post-update
  • Authentication and update loops lock users out of paid content despite active subscriptions
  • Monetization & Pricing
  • Technical Issues & Access
------
  • Inaccurate/Incomplete Database
  • Poor Search Functionality
Requests
  • Restoration of direct home screen access to the primary drug library database
--------
Strategic Intel
Strengths
  • Daily editorial updates establish clinical authority
  • Offline database access creates high switching costs
  • Massive database of 24,000+ peer-reviewed medications
  • Highly-rated visual Pill Identifier tool
  • Strong consumer brand trust (25M monthly visitors)
------
  • Drugs.com brand authority
  • AI-driven photo recognition
  • Integration with broader drug info ecosystem
Weaknesses
  • Persistent database download failures
  • UI navigation regressions hiding core tools
  • Authentication loops locking out paid subscribers
  • Aggressive $8.99/mo subscription pricing causing user friction
  • Technical bugs in v3.1.51 (login failures, UI duplication)
  • Manual entry for pill ID vs emerging AI camera scanning
------
  • High $9.99/week subscription cost
  • Database gaps for common/generic drugs
  • Search UI bugs (disappearing filters)
Pricingsubscriptionfreemiumfreesubscriptionfreefreefreefreefreemium
MomentumMaintenanceMaintenanceActiveIntenseMaintenanceIntenseSteadySteady-
Update Cadence5 versions, 1 majors/6mo, ~45d avg5 versions, ~26d avg5 versions5 versions5 versions5 versions5 versions5 versions-

Compare UpToDate Lexidrug head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by UpToDate Lexidrug, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0